Last reviewed · How we verify
NCT05815368: REMO
Efficacy of REMO Training for Hand Motor Recovery After Stroke
NA trial testing REMO in Stroke in 28 participants. Status unknown.
13 January 2025
Quick facts
| Lead sponsor | IRCCS San Camillo, Venezia, Italy |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 28 |
| Start date | 4 October 2022 |
| Primary completion | 13 January 2025 |
| Estimated completion | 13 January 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- REMO
- Task-Oriented Training
Conditions studied
- Stroke — all drugs for Stroke →
- Stroke, Ischemic — all drugs for Stroke, Ischemic →
- Stroke Hemorrhagic — all drugs for Stroke Hemorrhagic →
- Stroke Sequelae — all drugs for Stroke Sequelae →
Sponsor
IRCCS San Camillo, Venezia, Italy
Who can join
18 and older, any sex, with Stroke or Stroke, Ischemic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Upper limb motor impairment is one of the most common sequelae after stroke. Indeed, the recovery of upper limb sensory-motor functions remains one of the most important goals in stroke rehabilitation. In the last years, new approaches in neurorehabilitation field has been investigated to enhance motor recovery. The use of wearable devices combined with surface electromyography (i.e. sEMG) electrodes allows to detect patients muscle activation during motor performance. Moreover, sEMG is used to provide to the patients the biofeedback about their muscle activity during exercises execution to enhance motor control and motor recovery. The aim of the study is to define the efficacy of using REMO® (Morecognition srl, Turin,Italy) for hand motor recovery after stroke. A randomised-controlled trial will be conducted compared to a task-oriented training, in hand motor rehabilitation after stroke. 28 patients with diagnosis of first stroke event will be enrolled in this study. After randomization process, participants will be allocated in Experimental Group (REMO training) or in Control Group (task-oriented training). The participants will be assessed before and after the treatment and sEMG will be collected during 12 hand movements. The treatment will consist of 15 sessions (1h/day, 5day/week, 3 weeks). Finally, the sEMG of the same 12 hand movements will be collected from 15 healthy subjects to compare muscle activation with a normal reference model.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05815368
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other IRCCS San Camillo, Venezia, Italy trials
Trials by the same sponsor.
- NCT05956132 — Clinical and Biochemical Features for the Identification of Dominant Calpainopathies · unknown
- NCT05934188 — Exploring the Gut-Brain Axis in Ageing and Neurodegeneration · recruiting
- NCT06264037 — The Experience in Neurorehabilitation Setting: a Qualitative Study · unknown
- NCT06270420 — Technological Devices and Home Automation System in Neurological Rehabilitation · NA · unknown
- NCT05591040 — Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05815368 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS San Camillo, Venezia, Italy
- Last refreshed: 15 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05815368.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing